Showing results 1 to 20 of 40
next >
| Issue Date | Title | Author(s) |
| 2016 | Adenosine Triphosphate Regresses Endometrial Explants in a Rat Model of Endometriosis | Zhang, Chen; Gao, Li; Yi, Yanhong; Han, Hongjing; Cheng, Hongyan; Ye, Xue; Ma, Ruiqiong; Sun, Kunkun; Cui, Heng; Chang, Xiaohong |
| 3-Nov-2025 | Amplification of Extrachromosomal MYC Paralogs Shapes Immunosuppressive Tumor Microenvironment in Small Cell Lung Cancer | Zhang, Jingwei; Jin, Yueqi; Lin, Haodong; Deng, Jiaming; Ju, Yan; Hu, Xueyan; She, Jianqi; Liang, Zhijian; Dai, Kongxu; Qiu, Mantang; Sun, Kunkun; Wang, Jun; Yang, Fan; Chen, Jian; Yang, Ence; Li, Xiao |
| 1-Jun-2024 | Apatinib combined with ifosfamide and etoposide versus ifosfamide and etoposide in relapsed or refractory osteosarcoma (OAIE/PKUPH-sarcoma 11): A multicenter, randomized controlled trial | Xie, Lu; Xu, Jie; Sun, Xin; Liang, Xin; Liu, Kuisheng; Sun, Kunkun; Li, Yuan; Liu, Rong; Wang, Du; Shao, Shurong; Li, Peiyu; Pang, Zheng; Zhou, Guangxin; Wu, Sujia; Hua, Yingqi; Hu, Haiyan; Yang, Yi; Ji, Tao; Guo, Wei; Tang, Xiaodong |
| 2020 | Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study | Xie, Lu; Xu, Jie; Sun, Xin; Liu, Kuisheng; Li, Xiaowei; He, Fangzhou; Liu, Xinyu; Gu, Jin; Lv, Zhe; Yang, Rongli; Tang, Xiaodong; Yan, Taiqiang; Li, Dasen; Yang, Yi; Dong, Sen; Sun, Kunkun; Shen, Danhua; Guo, Wei |
| 2020 | Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial | Xie, Lu; Xu, Jie; Sun, Xin; Guo, Wei; Gu, Jin; Liu, Kuisheng; Zheng, Bingxin; Ren, Tingting; Huang, Yi; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Sun, Kunkun; Shen, Danhua; Li, Yuan |
| 2019 | Apatinib plus camrelizumab (SHR-1210) for unresectable high-grade osteosarcoma (APFAO) progressing after chemotherapy: A prospective, open label, phase II trial. | Xie, Lu; Guo, Wei; Xu, Jie; Sun, Xin; Liu, Kuisheng; Zheng, Bingxin; Ren, Ting; Huang, Yi; Tang, Xiaodong; Yan, Taiqiang; Yang, Rongli; Sun, Kunkun; Shen, Danhua; Li, Yuan |
| 20-May-2021 | Apatinib plus ifosfamide and etoposide (IE) versus IE chemotherapy alone for relapsed or refractory osteosarcoma. | Xie, Lu; Guo, Wei; Xu, Jie; Gu, Jin; Tang, Xiaodong; Li, Yuan; Sun, Kunkun |
| Jul-2021 | Apatinib plus ifosfamide and etoposide for relapsed or refractory osteosarcoma: A retrospective study in two centres | Xie, Lu; Xu, Jie; Sun, Xin; Li, Xiaowei; Liu, Kuisheng; Liang, Xin; Zhou, Zuli; Zhuang, Hongqing; Sun, Kunkun; Wu, Yiming; Gu, Jin; Guo, Wei |
| 25-Nov-2025 | Apatinib plus ifosfamide and etoposide versus ifosfamide and etoposide in patients with advanced osteosarcomas (OAIE/PKUPH-sarcoma 11): a randomized phase II study | Xie, Lu; Xu, Jie; Sun, Xin; Liu, Kuisheng; Sun, Kunkun; Li, Yuan; Liu, Rong; Wang, Du; Shao, Shurong; Chen, Zhongjiang; Pang, Zheng; Zhou, Guangxin; Wu, Sujia; Hua, Yingqi; Hu, Haiyan; Wei, Ran; Yang, Yi; Ji, Tao; Guo, Wei; Tang, Xiaodong |
| 2017 | Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma | Liu, Kuisheng; Ren, Tingting; Huang, Yi; Sun, Kunkun; Bao, Xing; Wang, Shidong; Zheng, Bingxin; Guo, Wei |
| 2017 | BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells | Wang, Shidong; Ren, Tingting; Jiao, Guangjun; Huang, Yi; Bao, Xing; Zhang, Fan; Liu, Kuisheng; Zheng, Bingxin; Sun, Kunkun; Guo, Wei |
| 2014 | Can surgical management of bone metastases improve quality of life among women with gynecologic cancer? | Ji, Tao; Eskander, Ramez; Wang, Yifei; Sun, Kunkun; Hoang, Bang H.; Guo, Wei |
| 10-Jun-2025 | Case report: a R0 resection successfully induced by T-DXd plus PD-1 inhibitor regimen in a primary unresectable stage IIIB NSCLC with ERBB2-mutation | Zhang, Ruijie; Cheng, Sida; Sun, Kunkun; Zhang, Lihong; Yan, Xiang; Yang, Fan |
| 26-Nov-2025 | CD3L1 expression and its association with the tumor microenvironment in 62 cases of osteosarcoma and Chordoma | Wang, Yuhang; Xu, Jiuhui; Deng, Shouyan; Sun, Kunkun; Wang, Yaqi; Ren, Tingting; Tang, Xiaodong; Xu, Jie; Xie, Lu |
| May-2024 | Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data | Pei, Guotian; Sun, Kunkun; Yang, Yingshun; Wang, Shuai; Li, Mingwei; Ma, Xiaoxue; Wang, Huina; Chen, Libin; Qin, Jiayue; Cao, Shanbo; Liu, Jun; Huang, Yuqing |
| 2017 | Combining of serial embolization and denosumab for large sacropelvic giant cell tumor Case report of 3 cases | Ji, Tao; Yang, Yi; Wang, Yifei; Sun, Kunkun; Guo, Wei |
| 31-Mar-2021 | Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China | Xie, Lu; Xu, Jie; Li, Xiaowei; Zhou, Zuli; Zhuang, Hongqing; Sun, Xin; Liu, Kuisheng; Liu, Xingyu; Sun, Kunkun; Wu, Yiming; Gu, Jin; Guo, Wei |
| Jul-2021 | Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade | Wang, Wei; Yan, Taiqiang; Guo, Wei; Niu, Jianfang; Zhao, Zhiqing; Sun, Kunkun; Zhang, Hongliang; Yu, Yiyang; Ren, Tingting |
| Jun-2021 | Different pathologic types of early stage lung adenocarcinoma have different post-operative recurrence patterns | Liu, Xianping; Sun, Kunkun; Yang, Fan; Sui, Xizhao; Jiang, Guanchao; Wang, Jun; Li, Xiao |
| 3-Feb-2024 | The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma | Xie, Lu; Sun, Xin; Xu, Jie; Liang, Xin; Liu, Kuisheng; Sun, Kunkun; Yang, Rongli; Tang, Xiaodong; Guo, Wei |
